Global and China Virus Like Particles Market Insights, Forecast to 2026
SKU ID : QYR-16504729 | Publishing Date : 05-Oct-2020 | No. of pages : 147
Detailed TOC of Global and China Virus Like Particles Market Insights, Forecast to 2026
1 Study Coverage1.1 Virus Like Particles Product Introduction
1.2 Market Segments
1.3 Key Virus Like Particles Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Virus Like Particles Market Size Growth Rate by Type
1.4.2 Adeno-Associated Virus
1.4.3 HIV
1.4.4 Hepatitis B Virus
1.4.5 Hepatitis C Virus
1.4.6 Other
1.5 Market by Application
1.5.1 Global Virus Like Particles Market Size Growth Rate by Application
1.5.2 Vaccines
1.5.3 Mycoviruses
1.5.4 Virus Research
1.5.5 Therapeutic and Imaging Agents
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Virus Like Particles Market Size, Estimates and Forecasts
2.1.1 Global Virus Like Particles Revenue 2015-2026
2.1.2 Global Virus Like Particles Sales 2015-2026
2.2 Global Virus Like Particles, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Virus Like Particles Historical Market Size by Region (2015-2020)
2.3.1 Global Virus Like Particles Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Virus Like Particles Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Virus Like Particles Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Virus Like Particles Sales Forecast by Region (2021-2026)
2.4.2 Global Virus Like Particles Revenue Forecast by Region (2021-2026)
3 Global Virus Like Particles Competitor Landscape by Players
3.1 Global Top Virus Like Particles Sales by Manufacturers
3.1.1 Global Virus Like Particles Sales by Manufacturers (2015-2020)
3.1.2 Global Virus Like Particles Sales Market Share by Manufacturers (2015-2020)
3.2 Global Virus Like Particles Manufacturers by Revenue
3.2.1 Global Virus Like Particles Revenue by Manufacturers (2015-2020)
3.2.2 Global Virus Like Particles Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Virus Like Particles Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Virus Like Particles Revenue in 2019
3.2.5 Global Virus Like Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Virus Like Particles Price by Manufacturers
3.4 Global Virus Like Particles Manufacturing Base Distribution, Product Types
3.4.1 Virus Like Particles Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Virus Like Particles Product Type
3.4.3 Date of International Manufacturers Enter into Virus Like Particles Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Virus Like Particles Market Size by Type (2015-2020)
4.1.1 Global Virus Like Particles Sales by Type (2015-2020)
4.1.2 Global Virus Like Particles Revenue by Type (2015-2020)
4.1.3 Virus Like Particles Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Virus Like Particles Market Size Forecast by Type (2021-2026)
4.2.1 Global Virus Like Particles Sales Forecast by Type (2021-2026)
4.2.2 Global Virus Like Particles Revenue Forecast by Type (2021-2026)
4.2.3 Virus Like Particles Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Virus Like Particles Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Virus Like Particles Market Size by Application (2015-2020)
5.1.1 Global Virus Like Particles Sales by Application (2015-2020)
5.1.2 Global Virus Like Particles Revenue by Application (2015-2020)
5.1.3 Virus Like Particles Price by Application (2015-2020)
5.2 Virus Like Particles Market Size Forecast by Application (2021-2026)
5.2.1 Global Virus Like Particles Sales Forecast by Application (2021-2026)
5.2.2 Global Virus Like Particles Revenue Forecast by Application (2021-2026)
5.2.3 Global Virus Like Particles Price Forecast by Application (2021-2026)
6 China by Players, Type and Application
6.1 China Virus Like Particles Market Size YoY Growth 2015-2026
6.1.1 China Virus Like Particles Sales YoY Growth 2015-2026
6.1.2 China Virus Like Particles Revenue YoY Growth 2015-2026
6.1.3 China Virus Like Particles Market Share in Global Market 2015-2026
6.2 China Virus Like Particles Market Size by Players (International and Local Players)
6.2.1 China Top Virus Like Particles Players by Sales (2015-2020)
6.2.2 China Top Virus Like Particles Players by Revenue (2015-2020)
6.3 China Virus Like Particles Historic Market Review by Type (2015-2020)
6.3.1 China Virus Like Particles Sales Market Share by Type (2015-2020)
6.3.2 China Virus Like Particles Revenue Market Share by Type (2015-2020)
6.3.3 China Virus Like Particles Price by Type (2015-2020)
6.4 China Virus Like Particles Market Estimates and Forecasts by Type (2021-2026)
6.4.1 China Virus Like Particles Sales Forecast by Type (2021-2026)
6.4.2 China Virus Like Particles Revenue Forecast by Type (2021-2026)
6.4.3 China Virus Like Particles Price Forecast by Type (2021-2026)
6.5 China Virus Like Particles Historic Market Review by Application (2015-2020)
6.5.1 China Virus Like Particles Sales Market Share by Application (2015-2020)
6.5.2 China Virus Like Particles Revenue Market Share by Application (2015-2020)
6.5.3 China Virus Like Particles Price by Application (2015-2020)
6.6 China Virus Like Particles Market Estimates and Forecasts by Application (2021-2026)
6.6.1 China Virus Like Particles Sales Forecast by Application (2021-2026)
6.6.2 China Virus Like Particles Revenue Forecast by Application (2021-2026)
6.6.3 China Virus Like Particles Price Forecast by Application (2021-2026)
7 North America
7.1 North America Virus Like Particles Market Size YoY Growth 2015-2026
7.2 North America Virus Like Particles Market Facts & Figures by Country
7.2.1 North America Virus Like Particles Sales by Country (2015-2020)
7.2.2 North America Virus Like Particles Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Virus Like Particles Market Size YoY Growth 2015-2026
8.2 Europe Virus Like Particles Market Facts & Figures by Country
8.2.1 Europe Virus Like Particles Sales by Country
8.2.2 Europe Virus Like Particles Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Virus Like Particles Market Size YoY Growth 2015-2026
9.2 Asia Pacific Virus Like Particles Market Facts & Figures by Country
9.2.1 Asia Pacific Virus Like Particles Sales by Region (2015-2020)
9.2.2 Asia Pacific Virus Like Particles Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Virus Like Particles Market Size YoY Growth 2015-2026
10.2 Latin America Virus Like Particles Market Facts & Figures by Country
10.2.1 Latin America Virus Like Particles Sales by Country
10.2.2 Latin America Virus Like Particles Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Virus Like Particles Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Virus Like Particles Market Facts & Figures by Country
11.2.1 Middle East and Africa Virus Like Particles Sales by Country
11.2.2 Middle East and Africa Virus Like Particles Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Corporation Information
12.1.2 GlaxoSmithKline Description and Business Overview
12.1.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GlaxoSmithKline Virus Like Particles Products Offered
12.1.5 GlaxoSmithKline Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Merck Virus Like Particles Products Offered
12.2.5 Merck Recent Development
12.3 Novavax
12.3.1 Novavax Corporation Information
12.3.2 Novavax Description and Business Overview
12.3.3 Novavax Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Novavax Virus Like Particles Products Offered
12.3.5 Novavax Recent Development
12.4 Takeda
12.4.1 Takeda Corporation Information
12.4.2 Takeda Description and Business Overview
12.4.3 Takeda Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Takeda Virus Like Particles Products Offered
12.4.5 Takeda Recent Development
12.5 Medicago
12.5.1 Medicago Corporation Information
12.5.2 Medicago Description and Business Overview
12.5.3 Medicago Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Medicago Virus Like Particles Products Offered
12.5.5 Medicago Recent Development
12.6 MedImmune
12.6.1 MedImmune Corporation Information
12.6.2 MedImmune Description and Business Overview
12.6.3 MedImmune Sales, Revenue and Gross Margin (2015-2020)
12.6.4 MedImmune Virus Like Particles Products Offered
12.6.5 MedImmune Recent Development
12.7 TechnoVax
12.7.1 TechnoVax Corporation Information
12.7.2 TechnoVax Description and Business Overview
12.7.3 TechnoVax Sales, Revenue and Gross Margin (2015-2020)
12.7.4 TechnoVax Virus Like Particles Products Offered
12.7.5 TechnoVax Recent Development
12.8 Agilvax
12.8.1 Agilvax Corporation Information
12.8.2 Agilvax Description and Business Overview
12.8.3 Agilvax Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Agilvax Virus Like Particles Products Offered
12.8.5 Agilvax Recent Development
12.9 Allergy Therapeutics
12.9.1 Allergy Therapeutics Corporation Information
12.9.2 Allergy Therapeutics Description and Business Overview
12.9.3 Allergy Therapeutics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Allergy Therapeutics Virus Like Particles Products Offered
12.9.5 Allergy Therapeutics Recent Development
12.10 Serum Institute of India
12.10.1 Serum Institute of India Corporation Information
12.10.2 Serum Institute of India Description and Business Overview
12.10.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Serum Institute of India Virus Like Particles Products Offered
12.10.5 Serum Institute of India Recent Development
12.11 GlaxoSmithKline
12.11.1 GlaxoSmithKline Corporation Information
12.11.2 GlaxoSmithKline Description and Business Overview
12.11.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.11.4 GlaxoSmithKline Virus Like Particles Products Offered
12.11.5 GlaxoSmithKline Recent Development
12.12 Cytos Biotechnology
12.12.1 Cytos Biotechnology Corporation Information
12.12.2 Cytos Biotechnology Description and Business Overview
12.12.3 Cytos Biotechnology Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Cytos Biotechnology Products Offered
12.12.5 Cytos Biotechnology Recent Development
12.13 ANGANY Genetics
12.13.1 ANGANY Genetics Corporation Information
12.13.2 ANGANY Genetics Description and Business Overview
12.13.3 ANGANY Genetics Sales, Revenue and Gross Margin (2015-2020)
12.13.4 ANGANY Genetics Products Offered
12.13.5 ANGANY Genetics Recent Development
12.14 CPL Biologicals
12.14.1 CPL Biologicals Corporation Information
12.14.2 CPL Biologicals Description and Business Overview
12.14.3 CPL Biologicals Sales, Revenue and Gross Margin (2015-2020)
12.14.4 CPL Biologicals Products Offered
12.14.5 CPL Biologicals Recent Development
12.15 Xiamen Innovax Biotech
12.15.1 Xiamen Innovax Biotech Corporation Information
12.15.2 Xiamen Innovax Biotech Description and Business Overview
12.15.3 Xiamen Innovax Biotech Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Xiamen Innovax Biotech Products Offered
12.15.5 Xiamen Innovax Biotech Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Virus Like Particles Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Virus Like Particles Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and China Virus Like Particles Market Insights, Forecast to 2026
List of TablesTable 1. Virus Like Particles Market Segments
Table 2. Ranking of Global Top Virus Like Particles Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Virus Like Particles Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Adeno-Associated Virus
Table 5. Major Manufacturers of HIV
Table 6. Major Manufacturers of Hepatitis B Virus
Table 7. Major Manufacturers of Hepatitis C Virus
Table 8. Major Manufacturers of Other
Table 9. Global Virus Like Particles Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Virus Like Particles Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Virus Like Particles Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Virus Like Particles Sales Market Share by Regions (2015-2020)
Table 13. Global Virus Like Particles Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Virus Like Particles Sales Forecast by Region (2021-2026) (K Pcs)
Table 15. Global Virus Like Particles Sales by Manufacturers (2015-2020) (K Pcs)
Table 16. Global Virus Like Particles Sales Share by Manufacturers (2015-2020)
Table 17. Global Virus Like Particles Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 18. Global Virus Like Particles by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Virus Like Particles as of 2019)
Table 19. Virus Like Particles Revenue by Manufacturers (2015-2020) (US$ Million)
Table 20. Virus Like Particles Revenue Share by Manufacturers (2015-2020)
Table 21. Key Manufacturers Virus Like Particles Price (2015-2020) (USD/Pcs)
Table 22. Virus Like Particles Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Virus Like Particles Product Type
Table 24. Date of International Manufacturers Enter into Virus Like Particles Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Virus Like Particles Sales by Type (2015-2020) (K Pcs)
Table 27. Global Virus Like Particles Sales Share by Type (2015-2020)
Table 28. Global Virus Like Particles Revenue by Type (2015-2020) (US$ Million)
Table 29. Global Virus Like Particles Revenue Share by Type (2015-2020)
Table 30. Virus Like Particles Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 31. Global Virus Like Particles Sales Share by Type (2021-2026)
Table 32. Global Virus Like Particles Sales by Application (2015-2020) (K Pcs)
Table 33. Global Virus Like Particles Sales Share by Application (2015-2020)
Table 34. Global Virus Like Particles Sales Share by Application (2021-2026)
Table 35. Global Virus Like Particles Sales Market Share Forecast by Application (2021-2026)
Table 36. Global Virus Like Particles Revenue by Application (2015-2020) (US$ Million)
Table 37. Global Virus Like Particles Revenue Market Share Forecast by Application (2021-2026)
Table 38. China Virus Like Particles Sales (K Pcs) of Key Companies (2015-2020)
Table 39. China Virus Like Particles Sales Share by Company (2015-2020)
Table 40. China Virus Like Particles Revenue (US$ Million) by Company (2015-2020)
Table 41. China Virus Like Particles Sales (K Pcs) by Type (2015-2020)
Table 42. China Virus Like Particles Sales Share by Type (2015-2020)
Table 43. China Virus Like Particles Revenue (US$ Million) Market Share by Type (2015-2020)
Table 44. China Virus Like Particles Price (K Pcs) by Type (2015-2020)
Table 45. China Virus Like Particles Sales (K Pcs) by Type (2021-2026)
Table 46. China Virus Like Particles Sales Share by Type (2021-2026)
Table 47. China Virus Like Particles Revenue (US$ Million) Market Share by Type (2021-2026)
Table 48. China Virus Like Particles Revenue Share by Type (2021-2026)
Table 49. China Virus Like Particles Price (K Pcs) by Type (2021-2026)
Table 50. China Virus Like Particles Sales (K Pcs) by Application (2015-2020)
Table 51. China Virus Like Particles Sales Share by Application (2015-2020)
Table 52. China Virus Like Particles Revenue (US$ Million) Market Share by Application (2015-2020)
Table 53. China Virus Like Particles Sales (K Pcs) by Application (2021-2026)
Table 54. China Virus Like Particles Sales Share by Application (2021-2026)
Table 55. China Virus Like Particles Revenue (US$ Million) Market Share by Application (2021-2026)
Table 56. China Virus Like Particles Revenue Share by Application (2021-2026)
Table 57. North America Virus Like Particles Sales by Country (2015-2020) (K Pcs)
Table 58. North America Virus Like Particles Sales Market Share by Country (2015-2020)
Table 59. North America Virus Like Particles Revenue by Country (2015-2020) (US$ Million)
Table 60. North America Virus Like Particles Revenue Market Share by Country (2015-2020)
Table 61. Europe Virus Like Particles Sales by Country (2015-2020) (K Pcs)
Table 62. Europe Virus Like Particles Sales Market Share by Country (2015-2020)
Table 63. Europe Virus Like Particles Revenue by Country (2015-2020) (US$ Million)
Table 64. Europe Virus Like Particles Revenue Market Share by Country (2015-2020)
Table 65. Asia Pacific Virus Like Particles Sales by Region (2015-2020) (K Pcs)
Table 66. Asia Pacific Virus Like Particles Sales Market Share by Region (2015-2020)
Table 67. Asia Pacific Virus Like Particles Revenue by Region (2015-2020) (US$ Million)
Table 68. Asia Pacific Virus Like Particles Revenue Market Share by Region (2015-2020)
Table 69. Latin America Virus Like Particles Sales by Country (2015-2020) (K Pcs)
Table 70. Latin America Virus Like Particles Sales Market Share by Country (2015-2020)
Table 71. Latin Americaa Virus Like Particles Revenue by Country (2015-2020) (US$ Million)
Table 72. Latin America Virus Like Particles Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Virus Like Particles Sales by Country (2015-2020) (K Pcs)
Table 74. Middle East and Africa Virus Like Particles Sales Market Share by Country (2015-2020)
Table 75. Middle East and Africa Virus Like Particles Revenue by Country (2015-2020) (US$ Million)
Table 76. Middle East and Africa Virus Like Particles Revenue Market Share by Country (2015-2020)
Table 77. GlaxoSmithKline Corporation Information
Table 78. GlaxoSmithKline Description and Business Overview
Table 79. GlaxoSmithKline Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. GlaxoSmithKline Virus Like Particles Product
Table 81. GlaxoSmithKline Recent Development
Table 82. Merck Corporation Information
Table 83. Merck Description and Business Overview
Table 84. Merck Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Merck Product
Table 86. Merck Recent Development
Table 87. Novavax Corporation Information
Table 88. Novavax Description and Business Overview
Table 89. Novavax Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Novavax Product
Table 91. Novavax Recent Development
Table 92. Takeda Corporation Information
Table 93. Takeda Description and Business Overview
Table 94. Takeda Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Takeda Product
Table 96. Takeda Recent Development
Table 97. Medicago Corporation Information
Table 98. Medicago Description and Business Overview
Table 99. Medicago Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Medicago Product
Table 101. Medicago Recent Development
Table 102. MedImmune Corporation Information
Table 103. MedImmune Description and Business Overview
Table 104. MedImmune Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. MedImmune Product
Table 106. MedImmune Recent Development
Table 107. TechnoVax Corporation Information
Table 108. TechnoVax Description and Business Overview
Table 109. TechnoVax Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 110. TechnoVax Product
Table 111. TechnoVax Recent Development
Table 112. Agilvax Corporation Information
Table 113. Agilvax Description and Business Overview
Table 114. Agilvax Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 115. Agilvax Product
Table 116. Agilvax Recent Development
Table 117. Allergy Therapeutics Corporation Information
Table 118. Allergy Therapeutics Description and Business Overview
Table 119. Allergy Therapeutics Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 120. Allergy Therapeutics Product
Table 121. Allergy Therapeutics Recent Development
Table 122. Serum Institute of India Corporation Information
Table 123. Serum Institute of India Description and Business Overview
Table 124. Serum Institute of India Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 125. Serum Institute of India Product
Table 126. Serum Institute of India Recent Development
Table 127. GeoVax Labs Corporation Information
Table 128. GeoVax Labs Description and Business Overview
Table 129. GeoVax Labs Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 130. GeoVax Labs Product
Table 131. GeoVax Labs Recent Development
Table 132. Cytos Biotechnology Corporation Information
Table 133. Cytos Biotechnology Description and Business Overview
Table 134. Cytos Biotechnology Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 135. Cytos Biotechnology Product
Table 136. Cytos Biotechnology Recent Development
Table 137. ANGANY Genetics Corporation Information
Table 138. ANGANY Genetics Description and Business Overview
Table 139. ANGANY Genetics Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 140. ANGANY Genetics Product
Table 141. ANGANY Genetics Recent Development
Table 142. CPL Biologicals Corporation Information
Table 143. CPL Biologicals Description and Business Overview
Table 144. CPL Biologicals Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 145. CPL Biologicals Product
Table 146. CPL Biologicals Recent Development
Table 147. Xiamen Innovax Biotech Corporation Information
Table 148. Xiamen Innovax Biotech Description and Business Overview
Table 149. Xiamen Innovax Biotech Virus Like Particles Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 150. Xiamen Innovax Biotech Product
Table 151. Xiamen Innovax Biotech Recent Development
Table 152. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 153. Key Challenges
Table 154. Market Risks
Table 155. Main Points Interviewed from Key Virus Like Particles Players
Table 156. Virus Like Particles Customers List
Table 157. Virus Like Particles Distributors List
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Virus Like Particles Product Picture
Figure 2. Global Virus Like Particles Sales Market Share by Type in 2020 & 2026
Figure 3. Adeno-Associated Virus Product Picture
Figure 4. HIV Product Picture
Figure 5. Hepatitis B Virus Product Picture
Figure 6. Hepatitis C Virus Product Picture
Figure 7. Other Product Picture
Figure 8. Global Virus Like Particles Sales Market Share by Application in 2020 & 2026
Figure 9. Vaccines
Figure 10. Mycoviruses
Figure 11. Virus Research
Figure 12. Therapeutic and Imaging Agents
Figure 13. Other
Figure 14. Virus Like Particles Report Years Considered
Figure 15. Global Virus Like Particles Market Size 2015-2026 (US$ Million)
Figure 16. Global Virus Like Particles Sales 2015-2026 (K Pcs)
Figure 17. Global Virus Like Particles Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Virus Like Particles Sales Market Share by Region (2015-2020)
Figure 19. Global Virus Like Particles Sales Market Share by Region in 2019
Figure 20. Global Virus Like Particles Revenue Market Share by Region (2015-2020)
Figure 21. Global Virus Like Particles Revenue Market Share by Region in 2019
Figure 22. Global Virus Like Particles Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Virus Like Particles Revenue in 2019
Figure 24. Virus Like Particles Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Virus Like Particles Sales Market Share by Type (2015-2020)
Figure 26. Global Virus Like Particles Sales Market Share by Type in 2019
Figure 27. Global Virus Like Particles Revenue Market Share by Type (2015-2020)
Figure 28. Global Virus Like Particles Revenue Market Share by Type in 2019
Figure 29. Global Virus Like Particles Market Share by Price Range (2015-2020)
Figure 30. Global Virus Like Particles Sales Market Share by Application (2015-2020)
Figure 31. Global Virus Like Particles Sales Market Share by Application in 2019
Figure 32. Global Virus Like Particles Revenue Market Share by Application (2015-2020)
Figure 33. Global Virus Like Particles Revenue Market Share by Application in 2019
Figure 34. China Virus Like Particles Sales Growth Rate 2015-2026 (K Pcs)
Figure 35. China Virus Like Particles Revenue Growth Rate 2015-2026 (US$ Million)
Figure 36. China Virus Like Particles Market Share in Global Market 2015-2026
Figure 37. China 5 and 10 Largest Virus Like Particles Players Market Share by Revenue in Virus Like Particles in 2019
Figure 38. China Virus Like Particles Revenue Share by Type (2015-2020)
Figure 39. China Virus Like Particles Revenue Growth Rate by Type in 2015 & 2019
Figure 40. China Virus Like Particles Revenue Share by Application (2015-2020)
Figure 41. China Virus Like Particles Revenue Growth Rate by Application in 2015 & 2019
Figure 42. North America Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. North America Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. North America Virus Like Particles Sales Market Share by Country in 2019
Figure 45. North America Virus Like Particles Revenue Market Share by Country in 2019
Figure 46. U.S. Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. U.S. Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Canada Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Canada Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Europe Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs)
Figure 51. Europe Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 52. Europe Virus Like Particles Sales Market Share by Country in 2019
Figure 53. Europe Virus Like Particles Revenue Market Share by Country in 2019
Figure 54. Germany Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Germany Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. France Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. France Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. U.K. Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 59. U.K. Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Italy Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 61. Italy Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Russia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. Russia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Asia Pacific Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs)
Figure 65. Asia Pacific Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 66. Asia Pacific Virus Like Particles Sales Market Share by Region in 2019
Figure 67. Asia Pacific Virus Like Particles Revenue Market Share by Region in 2019
Figure 68. China Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. China Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Japan Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Japan Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. South Korea Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. South Korea Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. India Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. India Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Australia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Australia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Taiwan Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Taiwan Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Indonesia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Indonesia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Thailand Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Thailand Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Malaysia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Malaysia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Philippines Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 87. Philippines Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Vietnam Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 89. Vietnam Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Latin America Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs)
Figure 91. Latin America Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 92. Latin America Virus Like Particles Sales Market Share by Country in 2019
Figure 93. Latin America Virus Like Particles Revenue Market Share by Country in 2019
Figure 94. Mexico Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Mexico Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Brazil Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Brazil Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Argentina Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 99. Argentina Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Middle East and Africa Virus Like Particles Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Virus Like Particles Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Virus Like Particles Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Virus Like Particles Revenue Market Share by Country in 2019
Figure 104. Turkey Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Virus Like Particles Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Virus Like Particles Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Porter's Five Forces Analysis
Figure 111. Virus Like Particles Value Chain
Figure 112. Channels of Distribution
Figure 113. Distributors Profiles
Figure 114. Bottom-up and Top-down Approaches for This Report
Figure 115. Data Triangulation
Figure 116. Key Executives Interviewed
Keyplayers in Global and China Virus Like Particles Market Insights, Forecast to 2026
GlaxoSmithKlineMerck
Novavax
Takeda
Medicago
MedImmune
TechnoVax
Agilvax
Allergy Therapeutics
Serum Institute of India
GeoVax Labs
Cytos Biotechnology
ANGANY Genetics
CPL Biologicals
Xiamen Innovax Biotech